KalVista Pharmaceuticals ... (KALV)
NASDAQ: KALV
· Real-Time Price · USD
11.85
0.10 (0.85%)
At close: Oct 03, 2025, 3:59 PM
12.05
1.69%
After-hours: Oct 03, 2025, 07:49 PM EDT
0.85% (1D)
| Bid | 11.3 |
| Market Cap | 598.7M |
| Revenue (ttm) | 1.43M |
| Net Income (ttm) | -203.1M |
| EPS (ttm) | -3.94 |
| PE Ratio (ttm) | -3.01 |
| Forward PE | -3.56 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 11.45 |
| Volume | 1,698,023 |
| Avg. Volume (20D) | 1,416,725 |
| Open | 11.81 |
| Previous Close | 11.75 |
| Day's Range | 11.61 - 11.93 |
| 52-Week Range | 7.30 - 17.28 |
| Beta | -0.15 |
| Ex-Dividend Date | n/a |
About KALV
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol KALV
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for KALV stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsKalVista Pharmaceuticals Inc. is scheduled to release its earnings on
Dec 4, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 week ago
-6.42%
KalVista shares are trading lower after the compan...
Unlock content with
Pro Subscription
1 week ago
-0.69%
KalVista Pharmaceuticals shares are trading lower after the company announced a $110 million private offering.
3 weeks ago · seekingalpha.com
KalVista Pharmaceuticals, Inc. (KALV) Q1 2026 Earnings Call TranscriptKalVista Pharmaceuticals, Inc. (NASDAQ:KALV ) Q1 2026 Earnings Call September 11, 2025 8:30 AM EDT Company Participants Ryan Baker - Head of Investor Relations Benjamin Palleiko - CEO & Director Nicol...
